# Cotempla XR-ODT

NDC: 70165-200
Generic name: Methylphenidate
Labeler / Manufacturer: Neos Therapeutics Brands, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20170620

FDA application: NDA205489

## Active ingredients

- METHYLPHENIDATE: 17.3 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70165-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70165-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33f70f58-c871-42c8-8adb-345caeafefcd